Segmental wall-motion abnormalities of the left ventricle predict arrhythmic events in patients with nonischemic cardiomyopathy

Heart Rhythm

Volumn 7, Issue 10, 2010, Pages 1390-1395

  Gaitonde, Rajdeep S ^a   Subbarao, Roopa ^a   Michael, Mark A ^a   Dandamudi, Gopi ^a   Bhakta, Deepak ^a   Mahenthiran, Jo ^a   Das, Mithilesh K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dilated cardiomyopathy; Ventricular arrhythmia; Wallmotion abnormality

Indexed keywords

ADULT; AKINESIA; ARTICLE; CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC DILATED CARDIOMYOPATHY; PRIORITY JOURNAL; QRS COMPLEX; SEGMENTAL WALL MOTION ABNORMALITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77957347771     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.05.039     Document Type: Article

References (39)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med 337 1997 1576 1583
2. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
3. A. Kadish, A. Dyer, and J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
4. A.S. Desai, J.C. Fang, W.H. Maisel, and K.L. Baughman Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879
5. E.B. Schron, D.V. Exner, and Q. Yao Quality of life in the Antiarrhythmics Versus Implantable Defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks Circulation 105 2002 589 594
6. J.E. Poole, G.W. Johnson, and A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
7. A.E. Buxton, K.L. Lee, and G.E. Hafley Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial Circulation 106 2002 2466 2472
8. S.L. Kusmirek, and M.R. Gold Sudden cardiac death: the role of risk stratification Am Heart J 153 2007 25 33
9. W. Grimm, J.J. Hoffmann, H.H. Muller, and B. Maisch Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30% J Am Coll Cardiol 39 2002 780 787
10. J. Mahenthiran, M.K. Das, D. Bhakta, W. Ghumman, H. Feigenbaum, and S.G. Sawada Prognostic importance of wall motion abnormalities in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator Am J Cardiol 98 2006 1301 1306
11. D.E. Wallis, J.B. O'Connell, R.E. Henkin, M.R. Costanzo-Nordin, and P.J. Scanlon Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign J Am Coll Cardiol 4 1984 674 679
12. L. Fauchier, V. Eder, and D. Casset-Senon Segmental wall motion abnormalities in idiopathic dilated cardiomyopathy and their effect on prognosis Am J Cardiol 93 2004 1504 1509
13. M.K. Das, W. Maskoun, and C. Shen Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy Heart Rhythm 7 2010 74 80
14. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 10 2006 e385 e484
15. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. T. Ryan, O. Petrovic, W.F. Armstrong, J.C. Dillon, and H. Feigenbaum Quantitative two-dimensional echocardiographic assessment of patients undergoing left ventricular aneurysmectomy Am Heart J 111 1986 714 720
17. P. Grambsch Proportional hazards tests and diagnostics based on weigheted residuals Biometrika 81 1994 515 526
18. K.A. Ellenbogen, J.H. Levine, and R.D. Berger Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
19. S.H. Hohnloser, T. Ikeda, and R.J. Cohen Evidence regarding clinical use of microvolt T-wave alternans Heart Rhythm 6 2009 S36 S44
20. W. Grimm, M. Christ, J. Bach, H.H. Muller, and B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 2003 2883 2891
21. W. Grimm, J. Hoffmann, V. Menz, K. Luck, and B. Maisch Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia J Am Coll Cardiol 32 1998 739 745
22. K.J. Makati, A.E. Fish, H.H. England, H. Tighiouart, N.A. Estes 3rd, and M.S. Link Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more Heart Rhythm 3 2006 397 403
23. R. Karaoguz, S. Maydanozcu, T. Altun, M. Guldal, O. Akyurek, and C. Erol Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up Int Heart J 47 2006 763 773
24. M. Zecchin, A. Di Lenarda, and A. Proclemer The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy Europace 6 2004 400 406
25. M. Zecchin, A. Di Lenarda, and D. Gregori Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy Ital Heart J 6 2005 721 727
26. S.H. Hohnloser, T. Klingenheben, D. Bloomfield, O. Dabbous, and R.J. Cohen Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study J Am Coll Cardiol 41 2003 2220 2224
27. A. Shiina, A.J. Tajik, H.C. Smith, M. Lengyel, and J.B. Seward Prognostic significance of regional wall motion abnormality in patients with prior myocardial infarction: a prospective correlative study of two-dimensional echocardiography and angiography Mayo Clin Proc 61 1986 254 262
28. S.S. Yao, E. Qureshi, A. Syed, and F.A. Chaudhry Novel stress echocardiographic model incorporating the extent and severity of wall motion abnormality for risk stratification and prognosis Am J Cardiol 94 2004 715 719
29. V. Rankovic, J. Karha, R. Passman, A.H. Kadish, and J.J. Goldberger Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy Am J Cardiol 89 2002 1072 1076
30. R.G. Assomull, S.K. Prasad, and J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
31. H.H. Hsia, D.J. Callans, and F.E. Marchlinski Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia Circulation 108 2003 704 710
32. N. de Leeuw, D.J. Ruiter, A.H. Balk, N. de Jonge, W.J. Melchers, and J.M. Galama Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy Transpl Int 14 2001 299 306
33. S.E. Hughes, and W.J. McKenna New insights into the pathology of inherited cardiomyopathy Heart 91 2005 257 264
34. P. Knaapen, R. Boellaard, and M.J. Gotte Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy J Nucl Med 45 2004 1299 1304
35. P. Ferrari, and G. Bianchi The genomics of cardiovascular disorders: therapeutic implications Drugs 59 2000 1025 1042
36. S. Yamaguchi, K. Tsuiki, M. Hayasaka, and S. Yasui Segmental wall motion abnormalities in dilated cardiomyopathy: hemodynamic characteristics and comparison with thallium-201 myocardial scintigraphy Am Heart J 113 1987 1123 1128
37. N. Maehashi, Y. Yokota, and A. Takarada The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy Analysis of 28 necropsy cases Jpn Heart J 32 1991 1 15
38. J.A. McCrohon, J.C. Moon, and S.K. Prasad Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
39. K. Soejima, W.G. Stevenson, J.L. Sapp, A.P. Selwyn, G. Couper, and L.M. Epstein Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars J Am Coll Cardiol 43 2004 1834 1842